top of page

About our Doctor

unnamed.png

Dr. Prasanna E D

MD Dermatology, Venerology & Leprosy

FRGUHS Aesthetic Dermatology

Dr Prasanna is a qualified dermatologist with expertise in clinical, procedural and aesthetic dermatology. He completed his M.D. in Dermatology, Venereology and Leprosy from Amrita Institute of Medical Sciences, Kochi, followed by advanced training in Aesthetic Dermatology and a senior residency at Christian Medical College, Vellore. He is committed to providing compassionate, evidence-based and personalised care, with a strong focus on patient safety and natural-looking outcomes. An award-winning researcher and author of multiple publications, he remains actively engaged in academic dermatology and advances in skin, hair and nail care.

5+

Years of experience

500+

patients treated

100+

procedures performerd

15 +

pubished chapters and articles

Publications

1.     Jagadeesan S, Duraisamy P. JAK inhibitors for eczematous conditions. In: Sardana K, editor. JAK Inhibitors in Dermatology. New Delhi, India: Jaypee Brothers Medical Publishers; 2023

 

2.      Duraisamy P, Panicker VV, Jose WM. Characterization and prognostic significance of cutaneous immune related adverse events in Indian patients on immune checkpoint inhibitor therapy. Dermatol Pract Concept. 2023;13(3):e2023127

 

3.     Jagadeesan S, Sajini L, Duraisamy P, Valliyil L. Cutaneous Chronic Graft versus Host Disease Mimicking Verruca Vulgaris. Indian J Dermatol. 2023;68(2):225-227

 

4.      Anjaneyan G, Duraisamy P, Kumar A, Manne S. Melioidosis presenting with Groove sign. J Dtsch Dermatol Ges. 2023;21(2):182-184

 

5.     Jagadeesan S, Duraisamy P, Panicker VV, Anjaneyan G, Sajini L, Velayudhan S, et al. Childhood Onset Erythrokeratoderma En Cocardes Treated with Oral Acitretin. Indian J Postgrad Dermatol 2023;1:93-5.

 

6.      Anjaneyan G, Duraisamy P, Pai R. Primary Herpetic Gingivostomatitis. Indian Dermatol Online J. 2022 Sep 21;14(1):148-149. doi: 10.4103/idoj.idoj_359_21

 

7.     Duraisamy P, Jagadeesan S. (2022). DLQI in Females: Important Disorders with Low DLQI. In: Sarkar, R., Sinha, S. (eds) Skin Diseases in Females. Springer, Singapore. https://doi.org/10.1007/978-981-16-6065-8_13

 

8.     Duraisamy P, Jagadeesan S, Thomas J. Tofacitinib in the treatment of refractory eczemas - a case series. J Dermatolog Treat. 2022;1-3.

 

9.     Anjaneyan G, Keechilat P, Duraisamy P, Eapen M. Ribociclib-induced extensive vitiligo-like lesions: possible pathomechanisms with clinical, dermoscopic and histological correlation. BMJ Case Rep. 2022;15(4):e248782.

 

10.  Duraisamy P, Jagadeesan S, Eapen M, Thomas J. Dipeptidyl peptidase-4 inhibitor-associated cutaneous eruptions: a retrospective observational study. Clin Exp Dermatol. 2022;47(7):1283-1290.

 

11.  Jagadeesan S, Duraisamy P, Panicker VV, Anjaneyan G et al. Cutaneous mercury granulomas, hyperpigmentation and systemic involvement: A case of mercury toxicity following herbal medication for psoriasis. Indian J Dermatol Venereol Leprol. 2021;87(6):892.

Awards

  1. Recipient of multiple paper and poster presentation awards at national and state dermatology conferences - MIDCUTICON Kerala, AAPUD, MIDDERMACON, ROOTS Bangalore, and the Dermatopathology Society of India conference.

  2. Awarded the IADVL Kerala Best Thesis Award 2022 for research on cutaneous adverse events of immune checkpoint inhibitors and their association with tumour response.

  3. Recognized with the Best Net Letter in IJDVL 2021 for a case report on cutaneous mercury toxicity following herbal medication for psoriasis.

bottom of page